Hos patienter med sekundær hyperkolesterolæmi forårsaget af hypothyreoidisme eller nefrotisk syndrom, bør den underliggende sygdom behandles før behandling med Crestor startes.
In patients with secondary hypercholesterolaemia caused by hypothyroidism or nephrotic syndrome, the underlying disease should be treated prior to initiating therapy with Crestor.